Stocks To Watch Today: Focus on Major Corporate Events, Government Approvals And Updates
Last Updated: 9th April 2026 - 02:09 pm
Summary:
On April 9, 2026, stocks are likely to gain focus based on earnings reports, governmental approvals, acquisition and other events from the energy, infrastructure, railways, and pharmaceutical sectors.
Join 5paisa and stay updated with Market News
Stocks that investors should follow on April 9, 2026, would come from the financial services, oil & gas, infrastructure, and pharmaceutical industries after some important announcements from their sides regarding earnings, acquisitions and governmental approvals.
Major Corporate Events
Anand Rathi Wealth Limited and GM Breweries Ltd. are some of the stocks under focus because these two firms have announced their earning results. Anand Rathi Wealth will also consider a bonus issue and dividend, according to company filings.
Info Edge India reported standalone billings of ₹1,057 crore, marking a 7.4% increase, driven by 9.5% growth in recruitment solutions and 21% growth in Jeevansathi, while Shiksha billings declined 12.9%, as per company data.
Bosch Limited announced it will acquire the entire stake in Bosch Chassis Systems India from Robert Bosch for approximately ₹9,069 crore through a mix of cash and non-cash consideration, according to regulatory filings.
Energy And Infrastructure Updates
Hindustan Petroleum Corporation Limited (HPCL) will remain in focus after the Union Cabinet approved an investment of about ₹79,459 crore for the Rajasthan refinery project with a capacity of 9 MMTPA, as per an official government release.
NHPC received government approval for an investment of around ₹26,070 crore for a 1,720 MW hydropower project in Arunachal Pradesh, according to a Cabinet statement.
NTPC signed a non-binding agreement with Électricité de France (EDF) to explore nuclear power projects in India, as per the company disclosure.
Orders And Contracts
KEC International secured orders worth approximately ₹2,518 crore across multiple segments, while RITES saw its railway siding contract from NALCO revised to about ₹119 crore, according to company filings.
Pharma And Consumer Updates
Lupin received U.S. FDA approval for Dapagliflozin and Metformin Hydrochloride tablets used in the treatment of type 2 diabetes, as per the company statement.
Redtape acquired the rights to international footwear brand SPRANDI for India and select markets, with plans to launch through online and retail channels.
Sectoral Triggers
Fertiliser stocks will be tracked after the government approved ₹41,534 crore under the nutrient-based subsidy scheme and increased gas supply to plants to 95%, according to official data.
Railway stocks may see movement following Cabinet approval of ₹13,038 crore for the Jaipur Metro Phase-2 project.
HMA Agro Industries will also be in focus as promoters plan to sell a 6.63% stake through an offer for sale at a floor price of ₹18 per share, as per exchange data.
These developments are expected to drive stock-specific action in the market during the session.
- Flat ₹20 Brokerage
- Next-gen Trading
- Advanced Charting
- Actionable Ideas
Trending on 5paisa
03
5paisa Capital Ltd
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.